Cargando…
Type I hypersensitivity reaction as a complication of lepa
Adverse drug reaction is defined as response to a drug which is noxious and unintended, and which occurs at doses normally used in man for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological functions. Type I hypersensitivity reaction is known as anaphylactic r...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702277/ https://www.ncbi.nlm.nih.gov/pubmed/26792959 http://dx.doi.org/10.4103/0976-0105.170583 |
_version_ | 1782408609433387008 |
---|---|
author | Janthli, Deepa Manjunath Chaturvedi, Ashutosh Somashekar, Shruthi Lohith, B. A. |
author_facet | Janthli, Deepa Manjunath Chaturvedi, Ashutosh Somashekar, Shruthi Lohith, B. A. |
author_sort | Janthli, Deepa Manjunath |
collection | PubMed |
description | Adverse drug reaction is defined as response to a drug which is noxious and unintended, and which occurs at doses normally used in man for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological functions. Type I hypersensitivity reaction is known as anaphylactic reaction which is due to immediate immunoglobulin E-mediated reaction. It is characterized by symptoms such as fever nausea, back pain, angiodema, rash, flushing, etc. Lepa generally refers to the application of pastes formed by mixing powder of herbs with water, milk, etc., and liquids. Complementary and alternative medicines are frequently used by the general population. Many people consider them to be without side effects. Ayurvedic treatment involves Shodhana (biopurification), Shaman (pacification), Bahya (external therapy), and Abhyantara karma's (internal therapy) for treating different diseases. One such bahya karma or external therapy is lepa. Even though lepa is said as “Aadhya Upakrama,” undue hypersensitivity is observed in many patients. A 60-year-old woman had an adverse reaction to lepa after being administered as an external medication. The observations were erythema, eruptions, and itching. Such case of hypersensitivity is discussed in the present study. |
format | Online Article Text |
id | pubmed-4702277 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-47022772016-01-20 Type I hypersensitivity reaction as a complication of lepa Janthli, Deepa Manjunath Chaturvedi, Ashutosh Somashekar, Shruthi Lohith, B. A. J Basic Clin Pharm Case Report Adverse drug reaction is defined as response to a drug which is noxious and unintended, and which occurs at doses normally used in man for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological functions. Type I hypersensitivity reaction is known as anaphylactic reaction which is due to immediate immunoglobulin E-mediated reaction. It is characterized by symptoms such as fever nausea, back pain, angiodema, rash, flushing, etc. Lepa generally refers to the application of pastes formed by mixing powder of herbs with water, milk, etc., and liquids. Complementary and alternative medicines are frequently used by the general population. Many people consider them to be without side effects. Ayurvedic treatment involves Shodhana (biopurification), Shaman (pacification), Bahya (external therapy), and Abhyantara karma's (internal therapy) for treating different diseases. One such bahya karma or external therapy is lepa. Even though lepa is said as “Aadhya Upakrama,” undue hypersensitivity is observed in many patients. A 60-year-old woman had an adverse reaction to lepa after being administered as an external medication. The observations were erythema, eruptions, and itching. Such case of hypersensitivity is discussed in the present study. Medknow Publications & Media Pvt Ltd 2015-12 /pmc/articles/PMC4702277/ /pubmed/26792959 http://dx.doi.org/10.4103/0976-0105.170583 Text en Copyright: © Journal of Basic and Clinical Pharmacy http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Case Report Janthli, Deepa Manjunath Chaturvedi, Ashutosh Somashekar, Shruthi Lohith, B. A. Type I hypersensitivity reaction as a complication of lepa |
title | Type I hypersensitivity reaction as a complication of lepa |
title_full | Type I hypersensitivity reaction as a complication of lepa |
title_fullStr | Type I hypersensitivity reaction as a complication of lepa |
title_full_unstemmed | Type I hypersensitivity reaction as a complication of lepa |
title_short | Type I hypersensitivity reaction as a complication of lepa |
title_sort | type i hypersensitivity reaction as a complication of lepa |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702277/ https://www.ncbi.nlm.nih.gov/pubmed/26792959 http://dx.doi.org/10.4103/0976-0105.170583 |
work_keys_str_mv | AT janthlideepamanjunath typeihypersensitivityreactionasacomplicationoflepa AT chaturvediashutosh typeihypersensitivityreactionasacomplicationoflepa AT somashekarshruthi typeihypersensitivityreactionasacomplicationoflepa AT lohithba typeihypersensitivityreactionasacomplicationoflepa |